Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Broadcom
AVGO
|
+$472M |
| 2 |
Advanced Micro Devices
AMD
|
+$296M |
| 3 |
Apple
AAPL
|
+$275M |
| 4 |
Qualcomm
QCOM
|
+$218M |
| 5 |
NVIDIA
NVDA
|
+$187M |
Top Sells
| 1 |
Amazon
AMZN
|
+$536M |
| 2 |
Uber
UBER
|
+$438M |
| 3 |
Chevron
CVX
|
+$280M |
| 4 |
Meta Platforms (Facebook)
META
|
+$264M |
| 5 |
CrowdStrike
CRWD
|
+$242M |
Sector Composition
| 1 | Technology | 19.65% |
| 2 | Healthcare | 18.08% |
| 3 | Consumer Discretionary | 13.75% |
| 4 | Industrials | 8.66% |
| 5 | Financials | 7.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Air T
AIRT
$66.1M
| $2.53M | ﹤0.01% |
118,511
+1,600
| +1% | +$34.1K |
|
1727
Glacier Bancorp
GBCI
$5.72B
| $2.52M | ﹤0.01% |
+67,592
| New | +$2.52M |
|
1728
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.12B
| $2.52M | ﹤0.01% |
35,000
+6,300
| +22% | +$453K |
|
1729
abrdn Physical Silver Shares ETF
SIVR
$2.6B
| $2.51M | ﹤0.01% |
90,200
+80,800
| +860% | +$2.25M |
|
1730
Mitsubishi UFJ Financial
MUFG
$178B
| $2.5M | ﹤0.01% |
231,900
+63,900
| +38% | +$690K |
|
1731
Evercore
EVR
$13.4B
| $2.5M | ﹤0.01% |
12,000
-6,300
| -34% | -$1.31M |
|
1732
Orion Group Holdings
ORN
$313M
| $2.5M | ﹤0.01% |
262,997
+1,200
| +0.5% | +$11.4K |
|
|
PSTX
1733
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $2.5M | ﹤0.01% |
854,900
+297,500
| +53% | +$869K |
|
1734
Kura Oncology
KURA
$702M
| $2.5M | ﹤0.01% |
121,200
-119,000
| -50% | -$2.45M |
|
1735
SPDR S&P Insurance ETF
KIE
$744M
| $2.49M | ﹤0.01% |
50,000
+26,100
| +109% | +$1.3M |
|
1736
Victoria's Secret
VSCO
$2.17B
| $2.49M | ﹤0.01% |
+140,700
| New | +$2.49M |
|
1737
Tradr 1.25X NVDA Bear Daily ETF
NVDS
$58.4M
| $2.48M | ﹤0.01% |
61,900
+38,300
| +162% | +$1.54M |
|
1738
Chemours
CC
$2.57B
| $2.48M | ﹤0.01% |
+109,881
| New | +$2.48M |
|
1739
Seneca Foods Class A
SENEA
$726M
| $2.47M | ﹤0.01% |
42,997
-14,500
| -25% | -$832K |
|
1740
Fluor
FLR
$6.52B
| $2.46M | ﹤0.01% |
56,500
-306,000
| -84% | -$13.3M |
|
1741
COPT Defense Properties
CDP
$3.44B
| $2.46M | ﹤0.01% |
98,300
-136,300
| -58% | -$3.41M |
|
1742
Green Plains
GPRE
$630M
| $2.46M | ﹤0.01% |
154,929
-218,000
| -58% | -$3.46M |
|
1743
Gambling.com
GAMB
$287M
| $2.46M | ﹤0.01% |
298,800
+12,000
| +4% | +$98.6K |
|
1744
Fox Class B
FOX
$23.9B
| $2.46M | ﹤0.01% |
76,700
-259,278
| -77% | -$8.3M |
|
1745
Innovative Solutions & Support
ISSC
$192M
| $2.45M | ﹤0.01% |
408,475
-11,312
| -3% | -$67.9K |
|
1746
Bombardier Recreational Products
DOOO
$4.68B
| $2.45M | ﹤0.01% |
38,200
-63,300
| -62% | -$4.05M |
|
|
GMRE
1747
Global Medical REIT
GMRE
$508M
| $2.44M | ﹤0.01% |
269,100
-29,000
| -10% | -$263K |
|
1748
American Outdoor Brands
AOUT
$110M
| $2.44M | ﹤0.01% |
271,068
+1,600
| +0.6% | +$14.4K |
|
1749
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.36B
| $2.43M | ﹤0.01% |
57,700
+37,900
| +191% | +$1.6M |
|
1750
Caribou Biosciences
CRBU
$160M
| $2.43M | ﹤0.01% |
+1,482,900
| New | +$2.43M |
|